Two Phase 3 Trials of Gantenerumab in Early Alzheimer’s Disease

Original Article

R.J. Bateman, J. Smith, M.C. Donohue, P. Delmar, R. Abbas, S. Salloway, J. Wojtowicz, K. Blennow, T. Bittner, S.E. Black, G. Klein, M. Boada, T. Grimmer, A. Tamaoka, R.J. Perry, R.S. Turner, D. Watson, M. Woodward, A. Thanasopoulou, C. Lane, M. Baudler, N.C. Fox, J.L. Cummings, P. Fontoura, and R.S. Doody

N Engl J Med 2023;389:1862-1876

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
11/15/2023
Course expires: 
11/16/2025

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Sunday, November 16, 2025 - 11:59pm.